Some people respond faster than the average, others slower, and a small number need to reach the higher doses before the effect fully takes hold
MISSED OPPORTUNITY FOR WOMEN'S HEALTH Lilly and Novo are testing their weight-loss drugs for a wide array of conditions, such as Parkinson's, Alzheimer's and substance abuse, but not PCOS
Second Natures peer-reviewed research directly compared both medications when combined with behavioural support, finding Mounjaro users lost 22.1% of their starting weight while Wegovy (up to 2.4 mg) users lost 17.1% at 12 months
A good functional practitioner will include either a full thyroid panel or an antibody test for TSI antibodies (thyroid stimulating immunoglobulins, the TSH receptor antibody that is the most common marker for Graves)
Use Afterpay or Klarna Pay-in-4 to split the first month into installments
Supports mental clarity Users commonly report clearer focus and concentration, noting it fits well into daily routines